C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.670
+0.080 (3.09%)
At close: Dec 5, 2025, 4:00 PM EST
2.642
-0.028 (-1.05%)
After-hours: Dec 5, 2025, 7:59 PM EST
C4 Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 259 | 254 | 278 | 289 | 1,566 | 1,426 | |
| Market Cap Growth | -11.67% | -8.73% | -3.60% | -81.55% | 9.83% | - | |
| Enterprise Value | 120 | 37 | 104 | 11 | 1,108 | 1,506 | |
| Last Close Price | 2.67 | 3.60 | 5.65 | 5.90 | 32.20 | 33.13 | |
| PS Ratio | 6.32 | 7.14 | 13.42 | 9.29 | 34.20 | 42.95 | |
| PB Ratio | 1.28 | 1.18 | 1.13 | 1.00 | 4.02 | 5.08 | |
| P/TBV Ratio | 1.68 | 1.18 | 1.13 | 1.00 | 4.02 | 5.08 | |
| EV/Sales Ratio | 4.00 | 1.03 | 5.02 | 0.35 | 24.20 | 45.36 | |
| Debt / Equity Ratio | 0.40 | 0.30 | 0.29 | 0.30 | 0.11 | 0.08 | |
| Asset Turnover | 0.09 | 0.10 | 0.05 | 0.07 | 0.10 | 0.13 | |
| Quick Ratio | 5.52 | 5.49 | 6.21 | 6.23 | 6.15 | 8.58 | |
| Current Ratio | 5.76 | 5.71 | 6.34 | 6.46 | 6.36 | 8.69 | |
| Return on Equity (ROE) | -59.98% | -45.58% | -49.50% | -37.76% | -25.03% | -47.41% | |
| Return on Assets (ROA) | -23.20% | -20.17% | -21.53% | -17.27% | -11.32% | -14.58% | |
| Return on Capital (ROIC) | -28.31% | -24.46% | -25.06% | -20.02% | -13.95% | -23.88% | |
| Return on Capital Employed (ROCE) | -51.90% | -38.50% | -41.70% | -33.50% | -18.00% | -17.00% | |
| Earnings Yield | -46.02% | -41.44% | -47.58% | -44.38% | -5.36% | -4.65% | |
| FCF Yield | -36.74% | -25.71% | -38.98% | -38.58% | -5.64% | -4.76% | |
| Buyback Yield / Dilution | -10.42% | -39.75% | -1.59% | -6.13% | -304.93% | -728.80% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.